Smith & Nephew Financial Report 2023
Smith & Nephew's financial report for 2023 highlights a significant increase in profit, strong revenue growth in sports medicine, and positive future outlook.
Smith & Nephew, a U.K. medical-technology company, has reported a significant increase in pretax profit for 2023, driven by strong revenue growth in its sports medicine segment and an enhanced trading margin.
Smith & Nephew anticipates underlying revenue growth for 2024 to be in the range of 5%-6% and aims for a trading profit margin of at least 18%. The company has affirmed its medium-term targets going forward.
Overall, the company's robust financial performance in 2023 showcases its resilience and strong market position.
Leave Comment